Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Danyi Wang

Showing results (31-40 of 36) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 36 results.
Biorxiv : the Preprint Server for Biology|February 19, 2024
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variantsShilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Cell Reports|July 12, 2023
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptideShuishu Wang, Flavio Matassoli, Baoshan Zhang, et al.
Nature Communications|July 24, 2025
HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptorsMia Madel Alfajaro, Emma L Keeler, Ning Li, et al.
Science Translational Medicine|September 3, 2025
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteinsSanjeev Kumar, Shilpi Jain, Bushra Wali, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Pageof 4

Showing results (31-40 of 36) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 36 results.
Biorxiv : the Preprint Server for Biology|February 19, 2024
XBB.1.5 monovalent booster improves antibody binding and neutralization against emerging SARS-CoV-2 Omicron variantsShilpi Jain, Sanjeev Kumar, Lilin Lai, et al.
Nature Communications|January 4, 2024
Cleavage-intermediate Lassa virus trimer elicits neutralizing responses, identifies neutralizing nanobodies, and reveals an apex-situated site-of-vulnerabilityJason Gorman, Crystal Sao-Fong Cheung, Zhijian Duan, et al.
Cell Reports|July 12, 2023
HIV-1 neutralizing antibodies elicited in humans by a prefusion-stabilized envelope trimer form a reproducible class targeting fusion peptideShuishu Wang, Flavio Matassoli, Baoshan Zhang, et al.
Nature Communications|July 24, 2025
HKU5 bat merbecoviruses engage bat and mink ACE2 as entry receptorsMia Madel Alfajaro, Emma L Keeler, Ning Li, et al.
Science Translational Medicine|September 3, 2025
The XBB.1.5 COVID-19 vaccine elicits a durable antibody response to ancestral and XBB.1.5 SARS-CoV-2 spike proteinsSanjeev Kumar, Shilpi Jain, Bushra Wali, et al.
Nature Immunology|September 3, 2024
Mucosal adenovirus vaccine boosting elicits IgA and durably prevents XBB.1.16 infection in nonhuman primatesMatthew Gagne, Barbara J Flynn, Shayne F Andrew, et al.
Pageof 4